Menu
← Oncology Approval Tracker
FDA DECISION ·
Mimrylo
rusfertide · Takeda Pharmaceuticals America
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Treatment of erythrocytosis in adults with polycythemia vera.
LAMPGEN ANALYSIS
Why it matters
The hepcidin mimetic gives patients a way to address red-cell overproduction in this myeloproliferative neoplasm. FDA's discussion of VERIFY centers on control of hematocrit and the burden of repeated phlebotomy.
What research teams should watch
Track baseline and follow-up hematocrit, phlebotomy eligibility and actual phlebotomy visits. These measures answer different operational questions about burden.
PRIMARY RECORDS